Jonathan David Schwartz - 03 Nov 2023 Form 4 Insider Report for Tabula Rasa HealthCare, Inc.

Role
Director
Signature
/s/ Brian W. Adams, by Power of Attorney
Issuer symbol
N/A
Transactions as of
03 Nov 2023
Net transactions value
$0
Form type
4
Filing time
14 Nov 2023, 20:59:36 UTC
Previous filing
13 Jun 2023
Next filing
03 Apr 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TRHC Common Stock Disposed to Issuer -17,582 -22% 60,806 03 Nov 2023 Direct F1
transaction TRHC Common Stock Disposed to Issuer -60,806 -100% 0 03 Nov 2023 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Jonathan David Schwartz is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Upon the consummation of the merger (the "Merger") contemplated by that certain Agreement and Plan of Merger, by and among Tabula Rasa HealthCare, Inc. (the "Company"), Locke Buyer, LLC and Locke Merger Sub, Inc., dated August 5, 2023 (the "Merger Agreement"), 17,582 shares of common stock of the Company ("Common Stock") were converted into the right to receive a cash payment of $184,611, representing the product obtained by multiplying (x) the number of shares of Common Stock owned by the reporting person, by (y) the offer price ($10.50).
F2 Upon the consummation of the Merger, pursuant to the Merger Agreement, 60,806 unvested restricted stock awards ("RSAs") were cancelled and converted into the right to receive a cash payment of $638,463, representing the product obtained by multiplying (x) the aggregate number of shares of Common Stock underlying the RSAs, by (y) the offer price ($10.50).